Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The ...

Interactive Chart for VNET Group, Inc. (VNET), analyze all the data with a huge range of indicators.